Dr. Shalini Sundar, MD

Dr. Sundar practices at Union City Dialysis Center in Fremont, California.

Dr. Sundar's NPI, 1780607838, was assigned on July 26, 2006. Dr. Sundar graduated from Bangalore Medical College in 2002. Dr. Sundar's California license number on file is A93518.

Dr. Sundar's primary practice is Union City Dialysis Center, at 39270 Paseo Padre Pkwy, Fremont, CA 94538 in Alameda County. The practice phone is (510) 489-6996.

Dr. Sundar's primary practice is Union City Dialysis Center in Fremont, California. Dr. Sundar is also affiliated with Washington Health. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Sundar to 4 more dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sundar practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Sundar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Sundar is board certified in internal medicine by the American Board of Internal Medicine. Dr. Sundar has a license on file in California.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and hypercalcemia among the conditions Dr. Sundar treats.

CMS data shows 2,202 Medicare services from Dr. Sundar across 11 procedure codes in 2024, for 368 Medicare patients. Medicare paid $265,719 for them.

CMS counts 368 Medicare patients who saw Dr. Sundar in 2024. The largest group is 75 to 84, with 126 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 59% are also on Medicaid. Their average risk score is 3.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sundar's median patient age at 76, with 43% women.

In 2024, Dr. Sundar wrote 1,324 Medicare Part D claims for 189 patients. 78% of them were for generic drugs. CMS names the drug for 1,179 of them, across 25 drugs with 11 or more claims each, at $294,831 in total drug cost. In 2023, CMS named 1,137 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Sundar for performance year 2024, reported as part of a group. Dr. Sundar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sundar as offering telehealth.

Dmand AI links 5 papers to Dr. Sundar, published from 2020 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Cartilage, Articular, Graphite and Proteoglycans. Dr. Sundar's most frequent co-author is Fernando Ivan Morales, MD.

CMS Open Payments shows 347 general payments to Dr. Sundar from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,044.

Dr. Sundar graduated from Bangalore Medical College in 2002.

Dr. Sundar is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.